BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17971613)

  • 1. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
    Rizzo WB
    Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
    Rizzo WB; Heinz E; Simon M; Craft DA
    Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection for Sjögren-Larsson syndrome.
    Kelson TL; Craft DA; Rizzo WB
    J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.
    S'aulis D; Khoury EA; Zabel M; Rizzo WB
    Mol Genet Metab; 2020; 131(1-2):253-258. PubMed ID: 32800643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren-Larsson syndrome.
    Rizzo WB
    Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
    Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
    Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.
    Rizzo WB; Dammann AL; Craft DA
    J Clin Invest; 1988 Mar; 81(3):738-44. PubMed ID: 3343337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of Sjögren-Larsson syndrome using enzymatic methods.
    Rizzo WB; Craft DA; Kelson TL; Bonnefont JP; Saudubray JM; Schulman JD; Black SH; Tabsh K; Dirocco M; Gardner RJ
    Prenat Diagn; 1994 Jul; 14(7):577-81. PubMed ID: 7971759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
    van den Brink DM; van Miert JM; Wanders RJ
    J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.
    Naganuma T; Takagi S; Kanetake T; Kitamura T; Hattori S; Miyakawa T; Sassa T; Kihara A
    J Biol Chem; 2016 May; 291(22):11676-88. PubMed ID: 27053112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
    Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma.
    Rizzo WB; Craft DA
    J Lipid Res; 2000 Jul; 41(7):1077-81. PubMed ID: 10884288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common deletion mutation in European patients with Sjögren-Larsson syndrome.
    Rizzo WB; Carney G; De Laurenzi V
    Biochem Mol Med; 1997 Dec; 62(2):178-81. PubMed ID: 9441870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.